{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:12:29Z","timestamp":1778314349843,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.nano.2025.102828","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T01:43:31Z","timestamp":1746927811000},"page":"102828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The potential of plasma-derived medium-sized extracellular vesicles as a biopsy alternative for active surveillance decisions in prostate Cancer"],"prefix":"10.1016","volume":"67","author":[{"given":"Kamil","family":"Szeliski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Fekner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Kasi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rasmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"\u015awito\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Sierakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Drewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Pokrywczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nano.2025.102828_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca-a Cancer Journal for Clinicians"},{"issue":"6","key":"10.1016\/j.nano.2025.102828_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca-a Cancer Journal for Clinicians"},{"issue":"2","key":"10.1016\/j.nano.2025.102828_bb0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eururo.2022.10.018","article-title":"Screening for prostate Cancer with prostate-specific antigen: the journey continues","volume":"83","author":"Albertsen","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.nano.2025.102828_bb0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bju.12854","article-title":"Guideline of guidelines: prostate cancer screening","volume":"114","author":"Loeb","year":"2014","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.nano.2025.102828_bb0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nano.2025.102828_bb0030","article-title":"Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis","volume":"362","author":"Ilic","year":"2018","journal-title":"BMJ-Br Med J"},{"issue":"66","key":"10.1016\/j.nano.2025.102828_bb0035","first-page":"1","article-title":"PSA in screening for prostate Cancer: more good than harm or more harm than good?","volume":"66","author":"Duffy","year":"2014","journal-title":"Adv Clin Chem"},{"issue":"8","key":"10.1016\/j.nano.2025.102828_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/pros.21122","article-title":"Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity","volume":"70","author":"Algotar","year":"2010","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.nano.2025.102828_bb0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.eururo.2020.06.026","article-title":"Re: reconsidering prostate Cancer mortality - the future of PSA screening: against increasing PSA threshold to 10\u2009ng\/mL","volume":"78","author":"Zlotta","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.nano.2025.102828_bb0050","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"2","key":"10.1016\/j.nano.2025.102828_bb0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.nano.2025.102828_bb0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.euo.2020.03.002","article-title":"Intermediate-risk prostate Cancer: stratification and management","volume":"3","author":"Preisser","year":"2020","journal-title":"European Urology Oncology"},{"issue":"11","key":"10.1016\/j.nano.2025.102828_bb0065","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jama.2009.1348","article-title":"Outcomes of localized prostate cancer following conservative management","volume":"302","author":"Lu-Yao","year":"2009","journal-title":"Jama-Journal of the American Medical Association"},{"key":"10.1016\/j.nano.2025.102828_bb0075","series-title":"EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022","author":"Urology, E.A.o","year":"2022"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.nano.2025.102828_bb0085","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v5.30829","article-title":"Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations","volume":"5","author":"Iwai","year":"2016","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.nano.2025.102828_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymeth.2020.02.002","article-title":"Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids","volume":"177","author":"Muraoka","year":"2020","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60619-w","article-title":"Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet - a neglected source for uEVs","volume":"10","author":"Musante","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.nano.2025.102828_bb0100","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jth.12554","article-title":"Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration","volume":"12","author":"Arraud","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0110","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"Journal of Extracellular Vesicles"},{"issue":"4","key":"10.1016\/j.nano.2025.102828_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cas.12896","article-title":"Extracellular vesicle transfer of cancer pathogenic components","volume":"107","author":"Fujita","year":"2016","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.nano.2025.102828_bb0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ptr.6273","article-title":"HIF-1 alpha\/VEGF signaling-mediated epithelial-mesenchymal transition and angiogenesis is critically involved in anti-metastasis effect of luteolin in melanoma cells","volume":"33","author":"Li","year":"2019","journal-title":"Phytother Res"},{"issue":"6","key":"10.1016\/j.nano.2025.102828_bb0135","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"7718","key":"10.1016\/j.nano.2025.102828_bb0140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.nano.2025.102828_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2025.102828_bb0150","series-title":"Absorption and Scattering of Light by Small Particles","author":"Bohren","year":"1998"},{"issue":"5","key":"10.1016\/j.nano.2025.102828_bb0155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1538-7836.2012.04683.x","article-title":"Single vs. swarm detection of microparticles and exosomes by flow cytometry","volume":"10","author":"Van der Pol","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.nano.2025.102828_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cyto.a.23782","article-title":"FCMPASS software aids extracellular vesicle light scatter standardization","volume":"97","author":"Welsh","year":"2020","journal-title":"Cytometry A"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-020-01589-x","article-title":"Emerging role of long noncoding RNA-encoded micropeptides in cancer","volume":"20","author":"Ye","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01155-z","article-title":"Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme","volume":"19","author":"Cheray","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50172-6","article-title":"Semen miRNAs contained in exosomes as non-invasive biomarkers for prostate cancer diagnosis","volume":"9","author":"Barcelo","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102828_bb0180","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v5.32945","article-title":"Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey","volume":"5","author":"Gardiner","year":"2016","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.nano.2025.102828_bb0185","article-title":"Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer","volume":"6","author":"Park","year":"2016","journal-title":"Sci Rep"},{"issue":"17","key":"10.1016\/j.nano.2025.102828_bb0190","first-page":"6357","article-title":"Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer","volume":"9","author":"Ross","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.nano.2025.102828_bb0195","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/0008-5472.727.65.3","article-title":"Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness","volume":"65","author":"Ghosh","year":"2005","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.nano.2025.102828_bb0200","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/pros.23901","article-title":"Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients","volume":"79","author":"Joncas","year":"2019","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent epcam protein expression in human carcinomas","volume":"35","author":"Went","year":"2004","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.nano.2025.102828_bb0210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jcp.24802","article-title":"Epithelial-to-mesenchymal transition induced by TGF-beta 1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells","volume":"230","author":"Gao","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.nano.2025.102828_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.777684","article-title":"A multivariate diagnostic model based on urinary EpCAM-CD9-positive extracellular vesicles for prostate cancer diagnosis","volume":"11","author":"Dai","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.nano.2025.102828_bb0220","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3892\/mmr.2014.2792","article-title":"microRNA-99a inhibits cell proliferation, colony formation ability, migration and invasion by targeting fibroblast growth factor receptor 3 in prostate cancer","volume":"11","author":"Wu","year":"2015","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.nano.2025.102828_bb0225","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-10-1031","article-title":"miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate Cancer cell proliferation","volume":"71","author":"Sun","year":"2011","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.nano.2025.102828_bb0230","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/onc.2013.77","article-title":"Regulation of several androgen-induced genes through the repression of the miR-99a\/let-7c\/miR-125b-2 miRNA cluster in prostate cancer cells","volume":"33","author":"Sun","year":"2014","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.nano.2025.102828_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197427","article-title":"Circulating miR-99a-5p expression in plasma: a potential biomarker for early diagnosis of breast Cancer","volume":"21","author":"Garrido-Cano","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.nano.2025.102828_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061064","article-title":"Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate Cancer","volume":"8","author":"Amir","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.nano.2025.102828_bb0245","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pros.21270","article-title":"miR-125b promotes growth of prostate Cancer xenograft tumor through targeting pro-apoptotic genes","volume":"71","author":"Shi","year":"2011","journal-title":"Prostate"},{"issue":"7","key":"10.1016\/j.nano.2025.102828_bb0250","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1007\/s11033-021-06568-7","article-title":"Identification of miRNA signatures and their therapeutic potentials in prostate cancer","volume":"48","author":"Karadag","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"11","key":"10.1016\/j.nano.2025.102828_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142373","article-title":"Dual action of miR-125b as a tumor suppressor and OncomiR-22 promotes prostate Cancer tumorigenesis","volume":"10","author":"Budd","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nano.2025.102828_bb0260","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euf.2017.02.018","article-title":"Diagnostic and prognostic MicroRNA biomarkers for prostate Cancer in cell-free urine","volume":"4","author":"Fredsoe","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.nano.2025.102828_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4412705","article-title":"MiR-145-5p inhibits the invasion of prostate Cancer and induces apoptosis by inhibiting WIP1","volume":"2021","author":"Sun","year":"2021","journal-title":"J Oncol"},{"issue":"6","key":"10.1016\/j.nano.2025.102828_bb0270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/07357907.2015.1025407","article-title":"Overexpression of miR-145-5p inhibits proliferation of prostate Cancer cells and reduces SOX2 expression","volume":"33","author":"Ozen","year":"2015","journal-title":"Cancer Investig"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0275","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1080\/21655979.2021.1945361","article-title":"MicroRNA miR-145-5p inhibits phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.nano.2025.102828_bb0280","article-title":"Microrna-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition","volume":"12","author":"Luo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2025.102828_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.790621","article-title":"miR-145-5p inhibits neuroendocrine differentiation and tumor growth by regulating the SOX11\/MYCN Axis in prostate cancer","volume":"13","author":"Ji","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.nano.2025.102828_bb0290","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.2147\/CMAR.S336671","article-title":"miR-145-5p: a potential biomarker in predicting gleason upgrading of prostate biopsy samples scored 3+3=6","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.nano.2025.102828_bb0295","first-page":"108","article-title":"LINC00641 regulates prostate cancer cell growth and apoptosis via the miR-365a-3p\/VGLL4 axis","volume":"25","author":"Liu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.nano.2025.102828_bb0300","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9306803","article-title":"Discovery and validation of serum MicroRNAs as early diagnostic biomarkers for prostate Cancer in Chinese population","volume":"2019","author":"Lyu","year":"2019","journal-title":"Biomed Res Int"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:52:55Z","timestamp":1778313175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"alternative-id":["S1549963425000280"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102828","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of plasma-derived medium-sized extracellular vesicles as a biopsy alternative for active surveillance decisions in prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102828"}}